Saudi German Health Successfully Concludes Impactful Second Annual Value-Based Quality Conference in Riyadh
Riyadh, Saudi Arabia, 28 November 2024 – Building on the success of its inaugural last year event, Saudi German Health concluded the second edition of the 'Value-Centric Quality Conference: Enhancing Outcomes Through Value-Based Healthcare (VBHC).' Held at the Narcissus The Royal Hotel in Riyadh, the event's primary objective was to set new standards of excellence in healthcare by fostering collaboration with global leaders in value-based healthcare (VBHC). SGH partnered with renowned international entities, including the International Consortium for Health Outcomes Measurement (ICHOM), Mayo Clinic, Ontario Health, and the Health Care Accreditation Council (HCAC) from Jordan.
The conference featured over 26 prominent speakers, including key leaders from Saudi Arabia's healthcare sector, representing organizations such as the Saudi Patient Safety Centre (SPSC), the Saudi Center for Organ Transplantation, the National Casemix Centre of Excellence, the Centre for Value in Health, the Council of Health Insurance, and King Saud University (KSU). It also attracted representatives from top insurance companies like Bupa, Tawuniya, and Al Rajhi Takaful, as well as major private sector hospitals such as Fakeeh Health and Dallah Hospital.
A highlight of the conference was the Value-Based Healthcare (VBHC) Yellow Belt Certification Workshop as part of SGH partnership with Decision Institute, which aimed to familiarize participants with the foundational VBHC concepts designed to enhance healthcare outcomes. The event also featured thought-provoking lectures and panel discussions with distinguished speakers like Jennifer Bright, President of ICHOM, and Dr. Reem Albunyan, CEO of Value in Health. Topics ranged from integrating digital health tools into VBHC models to exploring the transformative role of artificial intelligence (AI) in modern healthcare.
In a significant development, SGH celebrated becoming the first healthcare provider in the Kingdom to receive ICHOM accreditation, marking a milestone in advancing modern healthcare standards.
Makarem Sobhi Batterjee, President and Vice Chairman of Saudi German Health, expressed, 'This conference represents a crucial step in our mission to support the growth and development of the healthcare sector in Saudi Arabia. Quality and patient safety remain fundamental pillars in improving healthcare facilities.'
Dr. Ahmed Shebl, Group CEO of Saudi German Health, highlighted, 'The conference provided an excellent platform to showcase the latest developments and innovative solutions that can improve healthcare services. Our focus is to transform the healthcare sector by prioritizing quality.'
Dr. Mustafa Ghalwash, Chief Quality Officer at Saudi German Health, added, 'We are thrilled to organize the second Value-Based Quality Conference, which reflects our ongoing commitment to advancing the healthcare sector in the Kingdom. By emphasizing value-oriented quality, we aim to foster systemic improvements and enhance patient outcomes.'
The conference offered a unique opportunity for professionals across healthcare sectors—doctors, administrators, researchers, policymakers, and industry leaders—to share insights, engage in meaningful dialogue, and form strategic partnerships. This initiative further reinforced SGH's commitment to its ethos of 'Caring Like Family.'
Hashtags
- Health#VBHC,Value-CentricQualityConference:EnhancingOutcomesThroughValue-BasedHealthcare,Value-BasedHealthcare,YellowBeltCertificationWorkshop,Value-BasedQualityConference,JenniferBright,ReemAlbunyan,MakaremSobhiBatterjee,AhmedShebl,MustafaGhalwash,SaudiGermanHealth,SGH,ICHOM,NarcissusTheRoyalHotel,InternationalConsortiumforHealthOutcomesMeasurement,MayoClinic,OntarioHealth,HealthCareAccreditationCouncil,HCAC,SaudiPatientSafetyCentre,SPSC,SaudiCenterforOrganTransplantation,NationalCasemixCentreofExcellence,CentreforValueinHealth,CouncilofHealthInsurance,KingSaudUniversity,KSU,Bupa,Tawuniya,AlRajhiTakaful,FakeehHealth,DallahHospital,DecisionInstitute,ValueinHealth
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Syyaha
6 days ago
- Syyaha
Healthtrip launches Healinharam.com to strengthen Saudi Arabia's position as a global medical and wellness tourism hub
Riyadh: 2nd June 2025: Healthtrip, the world's largest health travel platform, has launched a dedicated digital platform that connects international tourists, particularly pilgrims, to a trusted network of medical, wellness, and chronic care servicesacross Makkah, Madinah, and Jeddah. The initiative directly supports Saudi Arabia's broader ambition to establish itself as a global hub for medical and wellness tourism, in line with Vision 2030. It also responds to increasing demand for high-quality care services during pilgrimage as the Kingdom continues to rapidly scale its healthcare infrastructure and wellness offerings. 'Muslims around the world spend over $20 billion on medical tourism, and a majority of these patients also travel to the holy cities for pilgrimage. With the recent launches of world-class hospitals and wellness retreats in Saudi Arabia, we recognized the increasing demand for quality care during pilgrimage seasons. This inspired the creation of Heal in Haram – a dedicated platform enabling customers to heal their bodies and souls, during a pilgrimage trip.' said Obaidullah Junaid, CEO, Healthtrip (Riyadh HQ). Through pilgrims can now book health screenings, wellness therapies, and essential treatments such as dialysis,chemotherapy, etc, at leading Saudi hospitals including Saudi German Hospital, Kings College Hospital, Fakeeh, Care Medical Makkah, Wellcare Medical by IMC, and Makkah Medical Center by Dallah – all through one integrated app. Dr. Ahmed Shebl, Group CEO of Saudi German Health, said, 'At the Saudi German group, we're very well placed to serve international patients and pilgrims, through our hospitals across the Holy Cities and Jeddah. In addition, we manage medical facilities in Mina and Arafa during Hajj to serve pilgrims from across the world. Recently, we became the first Saudi hospital to get the TEMOS accreditation for serving international patients. We've already started getting international patients through Healthtrip and are excited to partner with them in the Heal In Haram initiative '. According to the General Authority for Statistics (GASTAT), Saudi Arabia recorded 1.83 million Hajj pilgrims in 2024, with nearly 88% arriving from abroad, and a 31% surge during the fourth quarter of 2024 compared to the same quarter in 2023. Claire Smith, CEO, Kings College Hospital Jeddah, said, 'At Kings College Hospital, we are inspired with the opportunity of global tourists coming to the Kingdom. Our hospital in Jeddah brings the latest technology and top global talent together, offering patients world-class healthcare near the Holy Cities. We're excited to partner with Healthtrip and offer our executive health checkup and other treatments to pilgrims through Heal in Haram.' Danish Ahmed – Founder, Healthtrip said, 'The unprecedented growth in tourism is coming along with remarkable globalization of the Kingdom's healthcare landscape, making it an oasis of healing in the MENA region. addresses a real need for structured access to quality healthcare during pilgrimage. Additionally, there is a unique opportunity to promote Prophetic Medicine in wellness offerings, especially along the Kingdom's pristine coastlines and tranquil mountains. World-class retreats are also being developed in Medina – the city of tranquility – which is bound to attract thousands of wellness seekers from around the world. These developments created a compelling need for a dedicated platform to showcase the Kingdom's healthcare offerings to our global customer base. Since its inception, Healthtrip has served over 70,000 international patients from 42 countries, through a global network of 1,500+ accredited healthcare providers. With 6,800 channel partners and extensive experience in medical concierge services, the company offers tailored solutions in medical tourism, cosmetic care, wellness programs, and chronic condition management. With in-house health travel technology and tech-first approach – including multilingual AI chatbots and integrated scheduling tools, the comprehensive system ensures a seamless, end-to-end patient journey – from initial consultation and appointment booking to travel logistics, on-site support, and post-treatment follow-ups – all while upholding the highest standards of safety, dignity, and patient-centered care. Healthtrip plays a vital role in promoting premier healthcare destinations such as Saudi Arabia, helping to expand access to high-quality medical care while reducing travel barriers and enhancing patient trust.
Trade Arabia
15-05-2025
- Trade Arabia
Mayo Clinic's manufacturing engineers on the cusp of delivering new biotherapies
Manufacturing engineers are at the forefront of bringing new medicines derived from human sources such as cells, blood and genes to patients, Mayo Clinic has said. They produce what are often first-of-their kind biotherapies for diseases that previously had few or no treatment options. "The most interesting thing about our job is being able to be part of a team that brings transformative cell-based therapies to the clinic," says Kyle Ecker, Advanced Biomanufacturing Engineer Supervisor at Mayo Clinic in Florida. "It's incredibly fulfilling to understand the scientific basis of these therapies and watch them come to life by manufacturing products for individual patients." Mayo Clinic's Center for Regenerative Biotherapeutics has 40 manufacturing engineers in Rochester and Florida. Their work makes it possible for researchers to conduct studies that require cells to be engineered on a very short timeline. In some cases, they've been able to have cells taken from patients, manufactured and returned to them in a few weeks or less. Chimeric antigen receptor (CAR-T) cell therapy for B-cell cancers and a cell-based vaccine for ovarian cancer are two examples of experimental biotherapies manufactured at Mayo Clinic. "Our engineering teams are very dedicated to patients. They know the importance of their job, and that's to get these drugs manufactured successfully so they can be given to patients in clinical trials," says Snigdha Rai, senior director of advanced biomanufacturing in the Center for Regenerative Biotherapeutics. "Without the engineers there would be no biomanufacturing and no cell and gene therapies for patients." Manufacturing engineers work within a highly controlled laboratory setting or "clean room.' Clean rooms are facilities that operate according to current Good Manufacturing Practice (cGMP) regulations to ensure therapies are consistently manufactured and meet strict quality standards. These controlled environments have powerful purification systems to filter out pollutants such as dust, airborne particles, bacteria, fungus and mold that could compromise drug safety. Adherence to strict cleanliness guidelines dictates how engineers do their job. Before stepping into a clean room, they train extensively how to operate in a cGMP facility without triggering contamination. They perform techniques to keep everything extremely clean or sterile, using high dexterity skills such as taking the cap off a vial and putting it back on with one hand, while the other hand fills it with a chemical compound. They dress in coveralls or a "bunny suit" with a hood, goggles, face shield, double gloves and boot covers to block any escape of hair or skin cells. Once they've entered the clean room, their movements are slow and intentional. "Rapid movements or quick opening of doors could trigger the sensors that monitor for microscopic particles," Ecker explains. "People and materials must flow in a specific path to prevent any type of contamination. For example, we move in one direction, entering the clean room through one door while exiting through a separate door." Manufacturing engineers have the pivotal role of being the first to run processes that transform a cell and gene therapy from a discovery into experimental medicine for use in human clinical trials. They strictly follow standard operating procedures — a blueprint of sorts — to mass produce a new therapy. A minimum of two engineers work together at all times to ensure all cells are processed according to regulatory and quality standards. "The team works very closely each step of the way. We check each other's work and keep detailed records confirming that all procedures have been completed," says Qing Cindy Shao, Ph.D., lead advanced biomanufacturing engineer. "There is no room for error." An important function of the job is identifying when a procedure doesn't work as intended. The therapy is then sent back to the investigator and process development group to troubleshoot the issue and make appropriate changes. On-site manufacturing facilities make it possible to address the errors early and resolve them quickly. That helps minimize delays for patients. "Our manufacturing engineers are indispensable. They work with quality control, quality assurance and process development to ensure the therapy meets the requirements and are safe for patients," says Alina Oancea, manager of cGMP manufacturing. "When the processes work as intended, it takes about two weeks to manufacture a CAR-T cell product."
Trade Arabia
18-02-2025
- Trade Arabia
Saudi German Health seals partnership with BD Company
Saudi German Health (SGH), one of the leading healthcare providers in the region, has signed an agreement with BD Company, a global leader in advanced healthcare solutions, to transform healthcare services by introducing rapid diagnostic solutions. This collaboration is the first of its kind in the region, setting a new precedent for future innovations in healthcare. With an emphasis on state-of-the-art laboratory technologies, it will introduce advanced devices such as Bactec, Phoenix, Epicenter, and Maldi-Tof to significantly enhance diagnostic capabilities and improve patient care. The MoU was signed by Dr Ahmed Shebl, Group CEO of Saudi German Health and Riza Mutlak, Business Director at BD - Middle East, North Africa & Turkey, during a ceremony held recently at SGH's headquarters in Jeddah. According to SGH, the partnership aims to address existing challenges in microbiology by providing rapid and precise diagnostic solutions, thus establishing new standards for healthcare efficiency. The launch of these innovative lab devices will allow SGH to provide quicker, more accurate diagnoses, enhancing patient outcomes and elevating the quality of healthcare throughout the region, it stated. Makarem Sobhi Batterjee, Vice Chairman of Saudi German Health, said: "We are proud to partner with BD Company to introduce these advanced diagnostic devices to our laboratory. The deployment of these advanced lab devices marks a significant milestone in our ongoing commitment to providing the highest level of patient care." "More importantly, the goals of this collaboration align seamlessly with our brand ethos of 'Caring Like Family,' and we are excited to integrate these innovations into our processes," he stated. This partnership offers several key benefits. The Maldi-Tof device uses advanced technology to quickly and accurately detect a wide range of pathogens, including those that are difficult to culture, dramatically improving diagnostic accuracy and speed. By identifying the specific microorganisms responsible for infections, Maldi-Tof ensures the selection of the most effective antibiotics, mitigating the overuse of broad-spectrum antibiotics and combating antibiotic resistance. This partnership is expected to benefit more than 2 million patients annually, allowing the healthcare provider to deliver quicker, more accurate diagnostics and enhance patient outcomes. Philippe Villard, Senior Director of Commercial Operations, EMEA at BD Company, said: "We are excited to collaborate with Saudi German Health on this innovative initiative. The rollout of our advanced diagnostic solutions will significantly benefit healthcare providers by improving diagnostic accuracy and efficiency." "Technologies like Maldi-Tof have demonstrated their effectiveness in enhancing diagnostic outcomes in other regions, and we believe this collaboration will yield similar results in the Kingdom of Saudi Arabia," he stated. The rapid diagnostic solutions introduced by BD and SGH are expected to become a model for healthcare providers across the region, he added.- TradeArabia News Service
